Search results
Showing 4741 to 4755 of 8314 results
Recommendation ID IPG747/01 Question Evidence on the safety and efficacy of percutaneous image-guided cryoablation of peripheral neuroma
Recommendation ID IPG720/01 Question Evidence on the safety and efficacy of percutaneous insertion of a cystic duct stent after cholecystostomy
Recommendation ID IPG755/1 Question Evidence on the safety and efficacy of percutaneous thoracic duct embolisation for persistent chyle
Recommendation ID IPG694/1 Question Evidence on the safety and efficacy of permanent His-bundle pacemaker implantation for treating heart
Recommendation ID CG173/4 Question Factors affecting participation and quality of life:- What are the key factors, including additional
Recommendation ID NG11/4 Question Factors associated with sustained, high-quality residential care:- What factors (including service organisation
Recommendation ID NG52/2 Question Factors predicting outcomes for people with high-grade transformation of follicular lymphoma:- In people
Recommendation ID NG32/5 Question Factors that influence older people's mental wellbeing:- In the UK, which factors or processes in an
Recommendation ID NG134/3 Question What is the clinical and cost effectiveness, post-treatment and at longer-term follow‑up, of family
Recommendation ID NG75/2 Question Feeding interventions for the management of neonatal weight loss:- What is the effectiveness of feeding
Recommendation ID IPG668/1 Question Evidence on the safety and efficacy of fetoscopic prenatal repair of open neural tube defects in the
Recommendation ID NG144/1 Question For adults with fibromyalgia or persistent treatment-resistant neuropathic pain, what is the clinical
Recommendation ID NG3/7 Question In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring
Recommendation ID NG29/3 Question Fluid balance charts:- For children and young people receiving IV fluids, does the use of a standardised
Recommendation ID NG131/2 Question What is the most clinically and cost-effective follow‑up protocol for people with prostate cancer who